WallStreetZenWallStreetZen

NYSE: TAK
Takeda Pharmaceutical Co Ltd Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Takeda Pharmaceutical Co earnings were $1.3B for the trailing 12 months ending Dec 31, 2024, with 4.7% growth year over year. The latest TAK earnings report on Dec 31, 2024 announced Q4 2024 earnings of $152.4M, down 76.5% from last quarter. For the last reported fiscal year 2024 ending Mar 31, 2024, TAK reported annual earnings of $951.6M, with -60.3% growth. The next TAK earnings date is May 7, 2025.

TAK past earnings growth

How has TAK's earnings growth performed historically?

Company
4.73%
Industry
55.51%
Market
63.03%
TAK's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
TAK's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
TAK's earnings growth is accelerating... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

TAK earnings history

Current Revenue
$29.3B
Current Earnings
$1.3B
Current Profit Margin
4.5%

TAK Return on Equity

Current Company
2.8%
Current Industry
12.5%
Current Market
34.1%
TAK's Return on Equity (2.8%)... subscribe to Premium to read more.
High Return on Equity Performance

TAK undefined

Current Company
1.4%
Current Industry
5.5%
TAK is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when TAK announces earnings.

TAK undefined

Current Company
3.4%
Current Industry
12%
TAK's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

TAK vs Pharmaceutical Stocks

TickerEBITDAEarningsY/Y EarningsEPS
TAK$7.78B$1.35B-6.84%$0.43
HLN$3.12B$1.87B+3.82%$0.41
ZTS$3.85B$2.49B+11.74%$5.47
TEVA$1.08B-$1.64BN/A-$1.45
RDY$1.06B$668.31M+19.68%$0.80
View Top Pharmaceutical Stocks

TAK earnings dates

Next earnings date
May 7, 2025

Takeda Pharmaceutical Co Earnings Reports & History FAQ

What were Takeda Pharmaceutical Co's earnings last quarter?

On TAK's earnings call on Invalid Date, Takeda Pharmaceutical Co (NYSE: TAK) reported Q4 2024 earnings per share (EPS) of $0.05, up 79.83% year over year. Total TAK earnings for the quarter were $152.40 million. In the same quarter last year, Takeda Pharmaceutical Co's earnings per share (EPS) was $0.24.

If you're new to stock investing, here's how to buy Takeda Pharmaceutical Co stock.

When does Takeda Pharmaceutical Co report earnings?

The next TAK earnings date is Invalid Date. Add TAK to your watchlist to be reminded of Takeda Pharmaceutical Co's next earnings date.

What was TAK's earnings growth in the past year?

As of Takeda Pharmaceutical Co's earnings date in Invalid Date, Takeda Pharmaceutical Co's earnings has grown 4.73% year over year. This is 50.78 percentage points lower than the US Drug Manufacturers - Specialty & Generic industry earnings growth rate of 55.51%. TAK earnings in the past year totalled $1.35 billion.

Is Takeda Pharmaceutical Co profitable or losing money?

As of the last Takeda Pharmaceutical Co earnings report, Takeda Pharmaceutical Co is currently profitable. Takeda Pharmaceutical Co's net profit (also called net income) for the twelve months ending Dec 31, 2024 was $1.33 billion, a 5.82% increase year over year.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.